Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany ; volume:53 ; number:9 ; day:6 ; month:8 ; year:2024 ; pages:3663-3672 ; date:10.2024
Archives of sexual behavior ; 53, Heft 9 (6.8.2024), 3663-3672, 10.2024
- Creator
-
Valbert, Frederik Tim
Schmidt, Daniel
Kollan, Christian
Dröge, Patrik
Klein, Melanie
Schneider, Udo
Friebe, Martin
Wasem, Jürgen
Neumann, Anja
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10508-024-02922-5
- URN
-
urn:nbn:de:101:1-2411252107440.298093946656
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Valbert, Frederik Tim
- Schmidt, Daniel
- Kollan, Christian
- Dröge, Patrik
- Klein, Melanie
- Schneider, Udo
- Friebe, Martin
- Wasem, Jürgen
- Neumann, Anja
- SpringerLink (Online service)
Other Objects (12)
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Pre-Exposure Prophylaxis (PrEP)
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How
P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Pre-Exposure Prophylaxis (PrEP)
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How
P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Pre-Exposure Prophylaxis (PrEP)
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How
P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities